• Why Pharmacogenomics?

    Innovative practitioners are moving the medical and pharmaceutical industries from a one-size-fits-all approach to medicine to the more personalized, precision-based model of pharmacogenomics.

    Let's Talk

IMPROVING OUTCOMES

Pharmacogenomics for Today

Decades of research by the National Institutes of Health (NIH) and the pharmaceutical industry are rapidly coming to fruition. As clinical evidence for pharmacogenomics grows, the new challenge is how to interpret and apply it—in a meaningful way—into increasingly busy healthcare workflows.

Efficient Healthcare

Genomic data helps clinicians avoid trial-and-error prescribing, making medication management more efficient—and effective.

Increase Accuracy

Pharmacogenomic signatures allow healthcare providers to minimize adverse drug reactions and optimize efficacy by avoiding unsuited therapeutic regimens.

Improve Outcomes

With pharmacogenomics, organizations can improve the management of healthcare costs and improve quality of life for patients.

RESOURCES

Ready to see more?

Download an example report from Translational Software.
Access
SMARTER MEDICINE

Pharmacogenomics 101

pharma1
THE SCIENCE

What Is Pharmacogenomics?

Pharmacogenomics studies how genes affect a person’s response to medications by combining the fields of clinical pharmacology (the science of drugs) and genomics (the study of genes and what they do). The goal of pharmacogenomics is to incorporate genomic information into medication prescribing protocols.

pharma3
THE BENEFITS

Why Is Pharmacogenomics Important?

Every doctor knows from experience that some drugs do not work the same for everyone. Now, we have the knowledge to predict and avoid some of these issues and lessen the financial burden of hospitalizations and deaths caused by adverse drug reactions. Pharmacogenomics plays a vital role in helping to predict the efficacy of a medication and its dosing and to prevent adverse drug reactions.

pharma
THE TECH

How Is Translational Software Different?

To get the most out of pharmacogenomics, you need the technology to support turning genetic data into actionable data. As a SaaS provider, Translational Software is at the forefront of pharmacogenomics, offering solutions that are:

  • Evidence based: Decision support is based on the clinical guidance of expert groups.
  • Fully integrated: We speak FHIR®, LOINC, and HL7 to deliver the information you need in the context you need.
  • Able to facilitate interoperability: Our API is built on the Fast Healthcare Interoperability Resource (FHIR®) standard that is RESTful and uses OAuth.
  • Cost conscious: We deliver expert knowledge in a concise but comprehensive format at affordable prices.
placeholder_200x200
placeholder_200x200
placeholder_200x200
placeholder_200x200
TESTIMONIALS

What People Say

  • "Translational Software has taken the pioneering step of implementing the first pharmacogenomics solution that employs FHIR genomics for optimizing the prescription of patient medications, and has been a real leader in this arena."
    GIL ALTEROVITZ, PHD

    GIL ALTEROVITZ, PHD

    Gil Alterovitz, Ph.D., a Harvard Medical School professor and co-chair of HL7’s Clinical Genomics Work Group

  • "Integrating Translational Software’s PGx knowledge base within our e-prescribing platform allows us to deliver an in-workflow, evidence-based approach to medication prescribing that can be used as part of routine care."
    G. CAMERON DEEMER

    G. CAMERON DEEMER

    President of DrFirst